Decorinyl (Tripeptide-10 Citrulline)
Overview
Decorinyl is a modified tripeptide featuring citrulline substitution, engineered to interact with decorin, a small leucine-rich proteoglycan that regulates collagen fibrillogenesis. The peptide is proposed to enhance decorin production and activity in the dermis, thereby promoting organized collagen assembly and tensile strength. Its development targets improvement of dermal structural integrity in aging and photoaged skin.
Key Research Findings
Preclinical fibroblast culture assays have shown upregulation of decorin mRNA and improved alignment of collagen fibrils in three-dimensional matrix models. Clinical validation through randomized controlled trials has not been published in major dermatology journals as of recent literature reviews.
Topical
Research Phase
Interested in Decorinyl (Tripeptide-10 Citrulline)?
Find a verified provider experienced with Decorinyl (Tripeptide-10 Citrulline) protocols in your area. All providers are credentialed and use compliant sourcing.
Find a Decorinyl (Tripeptide-10 Citrulline) ProviderRelated Peptides
Afamelanotide (Scenesse)
FDA ApprovedA synthetic 13-amino acid analog of alpha-melanocyte-stimulating hormone (alpha-MSH) with a substitution of norleucine at position 4 that confers enhanced potency and enzymatic stability. Afamelanotide activates melanocortin-1 receptors (MC1R) on melanocytes, stimulating eumelanin production independent of UV exposure. The resulting increase in skin eumelanin provides photoprotection by absorbing UV radiation and scavenging reactive oxygen species.
Argireline (Acetyl Hexapeptide-8)
InvestigationalArgireline is a synthetic six amino acid peptide (Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2) designed to attenuate neurotransmitter release at the neuromuscular junction. It functions as a competitive inhibitor of the SNARE complex, reducing catecholamine release and potentially diminishing muscle contraction intensity in facial expression muscles. This mechanism provides a topical alternative rationale to botulinum toxin for addressing expression lines, though with markedly lower potency.
Matrixyl (Palmitoyl Pentapeptide-4)
InvestigationalMatrixyl is a lipopeptide composed of a pentapeptide sequence (Lys-Thr-Thr-Lys-Ser) attached to a palmitic acid moiety to enhance dermal penetration. It is proposed to stimulate fibroblast activity and upregulate synthesis of extracellular matrix components including collagen types I and III, fibronectin, and hyaluronic acid. The peptide serves as a matrikine fragment mimetic, signaling tissue remodeling pathways in aged or photodamaged skin.
Matrixyl 3000
InvestigationalMatrixyl 3000 is a proprietary combination of two lipopeptides: palmitoyl tripeptide-1 (Pal-GHK) and palmitoyl tetrapeptide-7 (Pal-GQPR). The formulation is designed to synergistically promote collagen and fibronectin synthesis while reducing interleukin-6 mediated inflammation in dermal fibroblasts. Both peptides carry palmitic acid for enhanced lipid solubility and stratum corneum permeation.